======= KIN =======
== Gene Information ==
* **Official Symbol**: KIN
* **Official Name**: Kin17 DNA and RNA binding protein
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=22944|22944]]
* **UniProt**: [[https://www.uniprot.org/uniprot/O60870|O60870]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=KIN&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20KIN|Open PubMed]]
* **OMIM**: [[https://omim.org/entry/601720|Open OMIM]]
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Involved in DNA replication and the cellular response to DNA damage. May participate in DNA replication factories and create a bridge between DNA replication and repair mediated by high molecular weight complexes. May play a role in illegitimate recombination and regulation of gene expression. May participate in mRNA processing. Binds, in vitro, to double-stranded DNA. Also shown to bind preferentially to curved DNA in vitro and in vivo (By similarity). Binds via its C-terminal domain to RNA in vitro. {ECO:0000250|UniProtKB:Q8K339, ECO:0000269|PubMed:11880372, ECO:0000269|PubMed:12359749, ECO:0000269|PubMed:12754299, ECO:0000269|PubMed:12853634, ECO:0000269|PubMed:15831485, ECO:0000269|PubMed:17045609}.
|Kin17 mid|
|double-stranded DNA binding|
|nuclear matrix|
|DNA replication|
|DNA recombination|
|mRNA processing|
|DNA repair|
|protein-containing complex|
|intracellular membrane-bounded organelle|
|mRNA metabolic process|
|viral process|
|DNA metabolic process|
|cellular response to DNA damage stimulus|
|symbiotic process|
|interspecies interaction between organisms|
|RNA processing|
|RNA binding|
|DNA binding|
|RNA metabolic process|
|cellular response to stress|
|cellular macromolecule biosynthetic process|
|macromolecule biosynthetic process|
|gene expression|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp80|RO-3307 4.7μM R02 exp80]]|-1.83|
|[[:results:exp453|B02 10μM R08 exp453]]|1.71|
|[[:results:exp412|THZ531 0.11 to 0.125 to 0.35μM on day4 then day6 R07 exp412]]|1.83|
|[[:results:exp410|THZ531 0.11 to 0.125μM on day4 R07 exp410]]|1.86|
|[[:results:exp413|THZ531 0.11 to 0.175μM on day4 R07 exp413]]|1.88|
|[[:results:exp32|Rifampicin 10μM R00 exp32]]|1.89|
|[[:results:exp238|Parthenolide 2.5μM R05 exp238]]|2.02|
|[[:results:exp153|SGC2096 2.6μM R03 exp153]]|2.19|
^Gene^Correlation^
|[[:human genes:p:psma6|PSMA6]]|0.435|
|[[:human genes:p:psmb4|PSMB4]]|0.424|
|[[:human genes:p:polr2j3|POLR2J3]]|0.42|
|[[:human genes:g:golga6l3|GOLGA6L3]]|0.413|
|[[:human genes:c:copg1|COPG1]]|0.411|
|[[:human genes:c:cdc5l|CDC5L]]|0.4|
Global Fraction of Cell Lines Where Essential: 582/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|1/1|
|909776.0|1/1|
|bile duct|19/28|
|blood|21/28|
|bone|22/26|
|breast|20/33|
|central nervous system|45/56|
|cervix|3/4|
|colorectal|16/17|
|esophagus|11/13|
|fibroblast|1/1|
|gastric|14/16|
|kidney|12/21|
|liver|9/20|
|lung|60/75|
|lymphocyte|15/16|
|ovary|22/26|
|pancreas|19/24|
|peripheral nervous system|14/16|
|plasma cell|15/15|
|prostate|1/1|
|skin|23/24|
|soft tissue|6/9|
|thyroid|2/2|
|upper aerodigestive|18/22|
|urinary tract|20/29|
|uterus|4/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 745
* **Expression level (log2 read counts)**: 5.18
{{:chemogenomics:nalm6 dist.png?nolink |}}